Endovia Health Sciences, Inc.
EDVA- Exchange
- NYSE
- Industry
- Beverages
- SEC CIK
- 0001553788
No open-market purchases or sales by Endovia Health Sciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $172.1K in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Endovia Health Sciences, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +2 vs. Q2 2022
- Shares held
- 2.07M
- −181.9K (−8.1%) vs. Q2 2022
- Total value
- $2.83M
- −$3.89M (−57.8%) vs. Q2 2022
- New holders
- 4
- 7 more added
- Sold out
- 2
- 5 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EDVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $172.1K |
| Q1 2026 | 16 | $243.9K |
| Q4 2025 | 14 | $150.7K |
| Q3 2025 | 17 | $255.7K |
| Q2 2025 | 12 | $260.9K |
| Q1 2025 | 11 | $93.4K |
| Q4 2024 | 34 | $720.8K |
| Q3 2024 | 31 | $1.04M |
| Q2 2024 | 32 | $903.3K |
| Q1 2024 | 28 | $1.37M |
| Q4 2023 | 30 | $1.40M |
| Q3 2023 | 28 | $1.61M |
| Q2 2023 | 26 | $2.93M |
| Q1 2023 | 21 | $3.45M |
| Q4 2022 | 24 | $2.19M |
| Q3 2022 | 23 | $2.83M |
| Q2 2022 | 22 | $6.81M |
| Q1 2022 | 25 | $7.96M |
| Q4 2021 | 15 | $484.0K |
| Q3 2021 | 13 | $919.0K |
| Q2 2021 | 9 | $1.01M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Endovia Health Sciences, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,135,405 | $1.55M | 0.00% | −167,836−12.9% | Reduced |
| Geode Capital Management, LLC | 214,499 | $293.0K | 0.00% | 00.0% | Unchanged |
| Parsons Capital Management Inc | 133,251 | $183.0K | 0.02% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 102,300 | $140.0K | 0.00% | −45,000−30.5% | Reduced |
| Citadel Advisors LLC | 79,320 | $109.0K | 0.00% | +43,825+123.5% | Added |
| Virtu Financial LLC | 71,022 | $97.0K | 0.01% | +71,022 | New |
| State Street Corp | 70,000 | $96.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 61,069 | $84.0K | 0.00% | −4,159−6.4% | Reduced |
| Northern Trust Corp | 42,618 | $58.0K | 0.00% | +11,271+36.0% | Added |
| Verition Fund Management LLC | 30,044 | $41.0K | 0.00% | +44+0.1% | Added |
| Cambridge Investment Research Advisors, Inc. | 24,264 | $33.0K | 0.00% | 00.0% | Unchanged |
| Sabby Management, LLC | 21,255 | $29.0K | 0.06% | −106,551−83.4% | Reduced |
| Bank of Montreal | 10,630 | $21.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 15,600 | $21.0K | 0.00% | +13,727+732.9% | Added |
| Marshall Wace, LLP | 15,343 | $21.0K | 0.00% | +15,343 | New |
| Simplex Trading, LLC | 13,845 | $18.0K | 0.00% | −4,996−26.5% | Reduced |
| Morgan Stanley | 12,201 | $17.0K | 0.00% | +3,001+32.6% | Added |
| Bank of New York Mellon Corp | 11,709 | $16.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 811 | $1.00K | 0.00% | +701+637.3% | Added |
| Wells Fargo & Company | 175 | $0 | 0.00% | +17+10.8% | Added |
| Gradient Investments LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 5 | $0 | 0.00% | +5 | New |
| Royal Bank of Canada | 128 | $0 | 0.00% | +128 | New |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −10,699−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1,750−100.0% | Sold out |
| TRH Financial, LLC | – | – | – | – | Not filed |